Search Results - "Lana, Susan E."

Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions by Das, Sunetra, Idate, Rupa, Lana, Susan E., Regan, Daniel P., Duval, Dawn L.

“…Soft tissue sarcomas (STS) are a heterogenous group of mesenchymal tumors representing over 50 distinct types with overlapping histological features and…”
Get full text

Author Correction: Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions by Das, Sunetra, Idate, Rupa, Lana, Susan E., Regan, Daniel P., Duval, Dawn L.

Get full text

Multi-omics approach identifies germline regulatory variants associated with hematopoietic malignancies in retriever dog breeds by Evans, Jacquelyn M, Parker, Heidi G, Rutteman, Gerard R, Plassais, Jocelyn, Grinwis, Guy C M, Harris, Alexander C, Lana, Susan E, Ostrander, Elaine A

“…Histiocytic sarcoma is an aggressive hematopoietic malignancy of mature tissue histiocytes with a poorly understood etiology in humans. A histologically and…”
Get full text

Canine salivary gland carcinoma treated with stereotactic body radiation therapy: a retrospective case series by Gualtieri, Patricia, Martin, Tiffany, Leary, Del, Lana, Susan E, LaRue, Susan M, Boss, Mary-Keara

“…The aim of this study was to describe the therapeutic outcomes of dogs with locally advanced salivary gland carcinomas (SGC) following stereotactic body…”
Get full text

Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma by Das, Sunetra, Idate, Rupa, Regan, Daniel P., Fowles, Jared S., Lana, Susan E., Thamm, Douglas H., Gustafson, Daniel L., Duval, Dawn L.

“…Osteosarcoma affects about 2.8% of dogs with cancer, with a one-year survival rate of approximately 45%. The purpose of this study was to characterize mutation…”
Get full text

Molecular landscape of canine soft tissue sarcoma by Das, Sunetra, Idate, Rupa, Regan, Daniel P., Lana, Susan E., Duval, Dawn L.

“…Canine soft tissue sarcomas (STS) are a heterogenous group of malignant tumors arising from mesenchymal cells of soft tissues. This simplified collective of…”
Get full text

Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985–1995) by Williams, Laurel E, Gliatto, John M, Dodge, Richard K, Johnson, Jeffrey L, Gamblin, Rance M, Thamm, Douglas H, Lana, Susan E, Szymkowski, Mary, Moore, Antony S

“…Objective—To characterize the signalment, clinical signs, biological behavior, and response to treatment of carcinoma of the apocrine glands of the anal sac in…”
Get full text

Pathology in Practice by Kline, Kyle, Dolan, Christopher, Young, Brian, Lana, Susan E, Vap, Linda, Dubielzig, Richard, Teixeira, Leandro, Henriksen, Michala de Linde

“…In collaboration with the American College of Veterinary Pathologists…”
Get full text

Colorado State University, Pet Hospice Program by Gore, Maria, Lana, Susan E, Bishop, Gail A

“…Serving clients since 2004, Colorado State University's Veterinary Teaching Hospital is the first and only program to offer a student-run pet hospice program…”
Get more information

Use of radiation and a slow-release cisplatin formulation for treatment of canine nasal tumors by Lana, S.E, Dernell, W.S, Lafferty, M.H, Withrow, S.J, LaRue, S.M

“…The purpose of this study was to evaluate the combined use of radiation and a slow‐release cisplatin chemotherapy formulation for treatment of malignant nasal…”
Get full text

Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs by Hillers, Kim R, Lana, Susan E, Fuller, Chana R, LaRue, Susan M

“…Medical records for 20 dogs with histologically confirmed nonsplenic hemangiosarcomas treated with palliative radiation therapy were reviewed to evaluate…”
Get more information

Characterizing the molecular and immune landscape of canine bladder cancer by Cronise, Kathryn E., Das, Sunetra, Hernandez, Belen G., Regan, Daniel P., Dailey, Deanna D., McGeachan, Robert I., Lana, Susan E., Page, Rodney L., Gustafson, Daniel L., Duval, Dawn L.

“…Transitional cell carcinoma (TCC), also known as urothelial carcinoma, is the most common bladder cancer in humans and dogs. Approximately one‐quarter of human…”
Get full text

Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B‐cell lymphoma treated with a 19‐week CHOP protocol by Wolf‐Ringwall, Amber, Lopez, Lynelle, Elmslie, Robyn, Fowler, Brooke, Lori, Janet, Sfiligoi, Gabriella, Skope, Anne, Arnold, Erin, Hughes, Kelly L., Thamm, Douglas H., Ehrhart, E. J., Avery, Anne C., Lana, Susan E.

“…Canine B‐cell lymphoma is a clinically heterogenous disease; however, it is generally treated as a single disease entity. The purpose of this clinical trial…”
Get full text

Intensity of perioperative analgesia but not pre‐treatment pain is predictive of survival in dogs undergoing amputation plus chemotherapy for extremity osteosarcoma by Nolan, Michael W., Uzan, Olivia C., Green, Noah A., Lana, Susan E., Lascelles, B. Duncan X.

“…The purpose of this bi‐institutional retrospective study was to determine whether, in dogs treated with limb amputation and adjunctive chemotherapy for…”
Get full text

Pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide in cats after oral, intravenous, and intraperitoneal administration of cyclophosphamide by Stroda, Katherine A, Murphy, Jacqueline D, Hansen, Ryan J, Brownlee, Lisa, Atencio, Elizabeth A, Gustafson, Daniel L, Lana, Susan E

“…OBJECTIVE To characterize pharmacokinetics of cyclophosphamide and 4-hydoxycyclophosphamide (4-OHCP) in the plasma of healthy cats after oral, IV, and IP…”
Get full text

An aggressive CD4−CD8− T‐cell neoplasm in young English bulldogs by Frankhouse, Kari A., Rout, Emily D., Hughes, Kelly L., Labadie, Julia D., Yoshimoto, Janna A., Lana, Susan E., Avery, Paul R., Avery, Anne C.

“…T‐cell leukemia/lymphoma accounts for roughly 30% of all types of lymphoproliferative neoplasia in dogs. Two forms of T‐cell lymphoma (T‐zone and peripheral…”
Get full text

Proliferative and Invasive Colorectal Tumors in Pet Dogs Provide Unique Insights into Human Colorectal Cancer by Wang, Jin, Wang, Tianfang, Sun, Yanfang, Feng, Yuan, Kisseberth, William C, Henry, Carolyn J, Mok, Irene, Lana, Susan E, Dobbin, Kevin, Northrup, Nicole, Howerth, Elizabeth W, Zhao, Shaying

“…Spontaneous tumors in pet dogs represent a valuable but undercharacterized cancer model. To better use this resource, we performed an initial global comparison…”
Get full text

Inflammation, Apoptosis, and Necrosis Induced by Neoadjuvant Fas Ligand Gene Therapy Improves Survival of Dogs With Spontaneous Bone Cancer by Modiano, Jaime F, Bellgrau, Donald, Cutter, Gary R, Lana, Susan E, Ehrhart, Nicole P, Ehrhart, EJ, Wilke, Vicki L, Charles, J Brad, Munson, Sibyl, Scott, Milcah C, Pozniak, John, Carlson, Cathy S, Schaack, Jerome, Duke, Richard C

“…Fas ligand (FasL) gene therapy for cancer has shown promise in rodents; however, its efficacy in higher mammals remains unknown. Here, we used intratumoral…”
Get full text

Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors by Hahn, Kevin A, Legendre, Alfred M, Shaw, Neil G, Phillips, Brenda, Ogilvie, Gregory K, Prescott, Deborah M, Atwater, Stephen W, Carreras, Janet K, Lana, Susan E, Ladue, Tracy, Rusk, Anthony, Kinet, Jean Pierre, Dubreuil, Patrice, Moussy, Alain, Hermine, Olivier

“…To evaluate the effectiveness of masitinib for the treatment of nonresectable mast cell tumors (MCTs) in dogs at 12 and 24 months after onset of treatment. 132…”
Get full text

Outcome and prognostic factors for osteosarcoma of the maxilla, mandible, or calvarium in dogs: 183 cases (1986-2012) by Selmic, Laura E, Lafferty, Mary H, Kamstock, Debra A, Garner, Alana, Ehrhart, Nicole P, Worley, Deanna R, Withrow, Stephen J, Lana, Susan E

“…To describe the biological behavior, clinical outcome, and prognostic factors of osteosarcoma of the maxilla, mandible, or calvarium in dogs. Retrospective…”
Get full text